Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis. | Front Immunol | 2022 | 36177043 | PubTator, text mining | PubMed |
| Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation. | Front Immunol | 2022 | 36172364 | PubTator, text mining | PubMed |
| Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy. | Front Genet | 2022 | 36171879 | PubTator, text mining | PubMed |
| Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. | Theranostics | 2022 | 36168626 | PubTator, text mining | PubMed |
| LIGHT deficiency attenuates acute kidney disease development in an in vivo experimental renal ischemia and reperfusion injury model. | Cell Death Discov | 2022 | 36163116 | PubTator, text mining | PubMed |
| Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy. | Proc Natl Acad Sci U S A | 2022 | 36161919 | PubTator, text mining | PubMed |
| MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. | Front Genet | 2022 | 36159990 | PubTator, text mining | PubMed |
| High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer. | Front Genet | 2022 | 36159964 | PubTator, text mining | PubMed |
| Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer. | J Oncol | 2022 | 36157232 | PubTator, text mining | PubMed |
| Nanomedicine approaches for treatment of hematologic and oncologic malignancies. | World J Clin Oncol | 2022 | 36157164 | PubTator, text mining | PubMed |
| Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity. | J Exp Med | 2022 | 36156707 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| The immune subtypes and landscape of sarcomas. | BMC Immunol | 2022 | 36153483 | PubTator, text mining | PubMed |
| Sarcoidosis and autoimmunity: In the depth of a complex relationship. | Front Med (Lausanne) | 2022 | 36148452 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma. | Comput Math Methods Med | 2022 | 36148016 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis on the expression and role of regulator of chromatin condensation 1/small nucleolar RNA host gene 3/small nucleolar RNA host gene 12. | Front Mol Biosci | 2022 | 36148010 | PubTator, text mining | PubMed |
| PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer. | J Inflamm Res | 2022 | 36147688 | PubTator, text mining | PubMed |
| N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma. | Front Genet | 2022 | 36147503 | PubTator, text mining | PubMed |
| The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer. | Vaccines (Basel) | 2022 | 36146529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=50